» Authors » Mohamed S Albannan

Mohamed S Albannan

Explore the profile of Mohamed S Albannan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 38
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Attallah K, Albannan M, Farid K, Rizk S, Fathy N
Technol Cancer Res Treat . 2024 Mar; 23:15330338241234790. PMID: 38436112
Hepatocellular carcinoma is frequently diagnosed in advanced stages, leading to a poorer prognosis. Therefore, early diagnosis and identification of biomarkers may significantly improve outcomes. This cross-sectional study enrolled 486 participants...
2.
Saadh M, Lafi F, Dahadha A, Albannan M
Vet World . 2022 Oct; 15(7):1617-1623. PMID: 36185515
Background And Aim: type A is an anaerobic bacterium that produces four major toxins (alpha, beta, epsilon, and iota) that cause various diseases. Most of the important -associated diseases of...
3.
Attallah A, Albannan M, Ghaly M, Sallam S, Amer M, Attia A
J Genet Eng Biotechnol . 2022 Jan; 20(1):13. PMID: 35080677
Background: Association between Helicobacter pylori (H. pylori) and chronic hepatitis C (CHC) still remains controversial. This work is concerned with assessing the potential role of H. pylori in the progression...
4.
Attallah A, El-Far M, Ghaly M, Omran M, Albannan M, Attallah A, et al.
Br J Biomed Sci . 2017 Apr; 74(2):95-100. PMID: 28367737
Background: There is controversial data in the literature about the characteristics and features of dual hepatitis B and hepatitis C infection. This work is concerned with estimating the extent to...
5.
Attallah A, Abdallah S, Albannan M, Omran M, Attallah A, Farid K
Am J Trop Med Hyg . 2016 Aug; 95(5):1044-1050. PMID: 27527625
Hepatitis C virus (HCV)/Schistosoma mansoni coinfection is common in Egypt and other developing countries. This study aimed to investigate the influence of HCV/S. mansoni coinfection on the concentration of HCV-nonstructural...
6.
Attallah A, El-Far M, Abdel Malak C, Farid K, Omran M, Yahya R, et al.
Ann Hepatol . 2015 Oct; 14(6):869-80. PMID: 26436359
Unlabelled: Background and rationale for the study. Continuing search for suitable tumor-markers is of clinical value in managing patients with various malignancies. These markers may be presented as intracellular substances...
7.
Attallah A, El-Far M, Abdel Malak C, Omran M, Shiha G, Farid K, et al.
Tumour Biol . 2015 May; 36(10):7667-74. PMID: 25929809
Currently, the search for suitable hepatocellular carcinoma (HCC) biomarkers is very intensive. Besides, efficacy and cost/effectiveness of screening and surveillance of cirrhotics for the diagnosis of HCC is still debated....
8.
Attallah A, El-Far M, Abdel Malak C, Omran M, Farid K, Hussien M, et al.
Ann Hepatol . 2015 Feb; 14(2):225-33. PMID: 25671832
Unlabelled: BACKGROUND AND RATIONALE FOR THE STUDY: The assessment of liver fibrosis provides useful information not only for diagnosis but also for therapeutic decision. This study was concerned with determining...
9.
Attallah A, El-Far M, Omran M, Farid K, Albannan M, El-Dosoky I
J Clin Lab Anal . 2013 Mar; 27(2):121-9. PMID: 23460258
Background: We aimed to derive a simple noninvasive test for liver-fibrosis staging and then estimate its performance against four simple noninvasive tests in chronic hepatitis C (CHC) patients. Methods: CHC...
10.
Attallah A, Omran M, Farid K, El-Bendary M, Emran T, Albannan M, et al.
Clin Chim Acta . 2012 Jul; 413(21-22):1725-30. PMID: 22759976
Background: This study aimed to develop and evaluate a predictive score named Fibrosis Routine Test (FRT) for liver fibrosis staging and to compare FRT with APRI, Lok, GUCI, FI, FibroQ,...